X @Forbes

Forbes·2025-09-26 21:30

Suma Krishnan spent decades working for other people before building a $4 billion biotech company based on her own inventions. Today, one of her FDA-approved drugs holds potential solutions for rare genetic diseases. #ForbesOver50 (Photo: Jamel Toppin) https://t.co/O3ytPUEJQv https://t.co/KHxfqxv6Su ...